Recent posts

TypePostAuthorRepliesLast updated
Blog entryHarvoni & Sovaldi, Xtandi in Top 20 Costliest Medicare Drugs Zack Struver040 weeks 5 days ago
Blog entryBloomberg: CVS Will Exclude Xtandi From Formulary in 2017 Zack Struver042 weeks 20 hours ago
Blog entryVivendi-SFR lobbyist nominated to WIPO Staff042 weeks 23 hours ago
Blog entryProposal for a WTO Agreement on the Supply of Public goods KEI Staff042 weeks 4 days ago
Blog entryLetter from 56 non-profits and experts to Secretary of State John Kerry on pressure on global access to medicines initiatives Zack Struver042 weeks 6 days ago
Blog entryWIPO GA 2013 to decide on future of the Intergovernmental Committee on Genetic Resources, Traditional Knowledge and Folklore thiru042 weeks 6 days ago
Blog entryRoger Bate: Eclectic booster of corporate views thiru044 weeks 5 days ago
Blog entrySeptember 2004: TACD's Future of WIPO Conference thiru044 weeks 6 days ago
Blog entryFrancis Gurry appoints Sylvie Forbin, lobbyist for Vivendi, as new head of copyright at WIPO James Love044 weeks 6 days ago
Page2016: KEI comments on NIH proposal for exclusive licenses to Chimeron Bio Corporation Diane Singhroy045 weeks 20 hours ago
Blog entryGates Foundation v. Teachscape: Restrictions on Patenting of Gates-Funded Inventions Andrew Goldman045 weeks 21 hours ago
Blog entrySCP 24 - A fruitful discussion? Staff045 weeks 6 days ago
Book pageKEI Achievements Staff046 weeks 21 hours ago
Blog entrySCP24: African Group submits revised proposal for a WIPO work program on Patents and Health thiru046 weeks 3 days ago
Blog entrySCP24: KEI statement on Patents and Health thiru047 weeks 1 hour ago
Blog entryApril 28, 2016 letter regarding US Senate Finance threats over compulsory license on Novartis cancer drug patents KEI Staff047 weeks 2 hours ago
PageWIPO SCCR 32 - links to KEI's reports from the meeting Manon Ress047 weeks 2 hours ago
PageNews reports on Senator Hatch pressure over Colombia compulsory license on Novartis drug James Love047 weeks 2 hours ago
Blog entryBriefing Call on National Institutes of Health (NIH) patent policies, 29 June 2016, 11:00 A.M. (EST) Zack Struver047 weeks 3 hours ago
Blog entrySCP24: KEI statement on exceptions and limitations to patent rights thiru047 weeks 19 hours ago
Blog entryStanding Committee on the Law of Patents (SCP) - GRULAC proposal - Revision of 1979 WIPO Model Law for Developing Countries thiru047 weeks 1 day ago
Blog entryColombia Issues Public Interest Declaration To Lower Price of Glivec KEI Staff047 weeks 5 days ago
Blog entryHuman Rights Council heats up during informal talks on the primacy of human rights over international trade and IP regimes thiru047 weeks 5 days ago
Blog entryS. Ward Casscells, Pentagon Medical Chief, Praised Army Role in Xtandi Development Zack Struver048 weeks 16 hours ago
Blog entryUS Chamber of Commerce defends Swiss drug company charging excessive prices in Colombia James Love049 weeks 1 day ago